Hostname: page-component-848d4c4894-2xdlg Total loading time: 0 Render date: 2024-06-22T06:41:47.401Z Has data issue: false hasContentIssue false
  • English
  • Français

Weight Gain, Hypothyroidism and Smoking Cessation

Published online by Cambridge University Press:  13 May 2016

Renee Bittoun ,
Ash Gargya  and
Linda Mann
Renee Bittoun*
Affiliation:
Royal Prince Alfred Hospital, Sydney Local Health District and The Smoking Research Unit, University of Sydney, Sydney, NSW, Australia
Ash Gargya
Affiliation:
Department of Endocrinology, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, NSW, Australia
Linda Mann
Affiliation:
Your Doctors, General Medical Practice, Sydney, NSW, Australia
*
Address for correspondence: Renee Bittoun, Smoking Research Unit, Brain Mind Research Centre, University of Sydney, Sydney, NSW, Australia. Email: renee.bittoun@sydney.edu.au
Get access Rights & Permissions [Opens in a new window]

Extract

The case study received ethics approval from Sydney Local Health District Ethics Review Committee.

Type
Protocol
Information
Journal of Smoking Cessation , Volume 12 , Issue 2 , June 2017 , pp. 86 - 87
Copyright
Copyright © The Author(s) 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alzoubi, K. H., & Alkadhi, K. A. (2014). Chronic nicotine treatment reverses hypothyroidism-induced impairment of L-LTP induction phase: Critical role of CREB. Molecular Neurobiology, 49 (3), 1245–1255.Google Scholar
American Psychiatric Association. (2013). Tobacco use disorder. In Diagnostic and statistical manual of mental disorders, Fifth Edition (DSM-5®) (pp. 571). American Psychiatric Publishing.Google Scholar
Åsvold, B. O., Bjøro, T., Nilsen, T. I. L., & Vatten, L. J. (2007). Tobacco smoking and thyroid function: A population-based study. Archives of Internal Medicine, 167 (13), 1428–1432. American Medical Association.Google Scholar
Bittoun, R., Kentaro, S., Elcombe, E. L., & Takata, A. (2014). International inconsistencies of predicted expired carbon monoxide in non-smokers: The Australian experience. Presented at the 2014 Society for Research on Nicotine and Tobacco (SRNT) 20th Annual Meeting, Seattle.Google Scholar
Carlé, A., Bülow Pedersen, I., Knudsen, N., Perrild, H., Ovesen, L., Banke Rasmussen, L. et al. (2012). Smoking cessation is followed by a sharp but transient rise in the incidence of overt autoimmune hypothyroidism - a population-based, case-control study. Clinical Endocrinology, 77 (5), 764–772.Google Scholar
Krassas, G. E., & Wiersinga, W. (2006). Smoking and autoimmune thyroid disease: The plot thickens. European Journal of Endocrinology/European Federation of Endocrine Societies, 154 (6), 777–780.Google Scholar
Laurberg, P., Andersen, S., Pedersen, I. B., Knudsen, N., & Carlé, A. (2013). Prevention of autoimmune hypothyroidism by modifying iodine intake and the use of tobacco and alcohol is manoeuvring between Scylla and Charybdis. Hormones (Athens, Greece), 12 (1), 30–38.Google Scholar
Schmeltz, L. R., Blevins, T. C., Aronoff, S. L., Ozer, K., Leffert, J. D., Goldberg, M. A. et al. (2014). Anatabine supplementation decreases thyroglobulin antibodies in patients with chronic lymphocytic autoimmune (Hashimoto's) thyroiditis: a randomized controlled clinical trial. The Journal of Clinical Endocrinology and Metabolism, 99 (1), E137–E142.Google Scholar
Vestergaard, P. (2002). Smoking and thyroid disorders - a meta-analysis. European Journal of Endocrinology/European Federation of Endocrine Societies, 146 (2), 153–161.Google Scholar
Wiersinga, W. M. (2012). Thyroid function: Quitting smoking-transient risk of autoimmune hypothyroidism. Nature reviews. Endocrinology, 8 (9), 509–510.Google Scholar